Evidence map›Paper›PMID 38372875›Full record

ArticleInternational journal of hematology2024

Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders.

Hiroshi Kawabata, Naoki Miyazawa, Yumi Matsuda, Misaki Satobe, Yasushi Mizogami, Yoko Kuriyama, Tomomi Sakai, Minako Mori, Michio Sasa

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hiroshi KawabataDepartment of Hematology, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata-Cho, Fushimi-Ku, Kyoto, 612-8555, Japan. hkawabat@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-1918-8635
Naoki MiyazawaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Yumi MatsudaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Misaki SatobeDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Yasushi MizogamiDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Yoko KuriyamaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Tomomi SakaiDepartment of Hematology, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata-Cho, Fushimi-Ku, Kyoto, 612-8555, Japan.
Minako MoriDepartment of Hematology, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata-Cho, Fushimi-Ku, Kyoto, 612-8555, Japan.
Michio SasaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, Kyoto, Japan.
Kyoto Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron is an essential trace metal, vital for various physiologic processes, but excess levels can harm health. Maintaining iron homeostasis is critical, with hepcidin playing a key role. The isoform hepcidin-25 exerts the most significant influence on iron metabolism, making its serum levels a valuable diagnostic tool. However, mass-spectrometry and other conventional measurement methods can be difficult to perform, and some immunoassays lack reliability. In this study, we employed a recently developed latex agglutination method integrated with a readily available automated analyzer to quantify serum hepcidin-25 levels in both volunteers recruited from personnel of our hospital (n = 93) and patients with various hematological disorders (n = 112). Our findings unveiled a robust positive correlation between serum hepcidin-25 and ferritin, as well as C-reactive protein levels, in both volunteers and patients. Among the patients with hematological disorders, there was a noteworthy negative correlation between hepcidin-25 levels and hemoglobin concentrations, as well as reticulocyte counts. Interestingly, the hepcidin-25/ferritin ratio was remarkably low in patients with hemolytic anemia and myelodysplastic syndromes with ring sideroblasts. Our findings suggest that quantifying serum hepcidin-25 and the hepcidin-25/ferritin ratio using this method may be valuable for screening of hematopoietic diseases and other iron metabolism disorders.

Indexed as

HepcidinsMyelodysplastic SyndromesFerritinsHealthy VolunteersHumansIronLatex Fixation TestsReproducibility of ResultsFerritinsHepcidinsIronErythropoiesisFerritinHepcidinIron metabolismMyelodysplastic syndromes

Identifiers

PMID38372875
OpenAlexW4391927429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.